Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IGS | News: IGS Ghana returns to gold top spot as output jumps 32% | 10/06/23 | 0 | 326 | |||
|
|||||||
IGS | Ann: Company Update | 20/05/23 | 24 | 12K | |||
|
|||||||
IGS | Ann: Removal from Official List | 14/05/19 | 7 | 10K | |||
|
|||||||
IGS | News: IGS International Goldfields To Be De-listed On Monday, March 18 | 15/03/19 | 0 | 677 | |||
|
|||||||
IGS | Update | 23/02/19 | 15 | 6.8K | |||
|
|||||||
IGS | Relisting | 24/10/18 | 8 | 4.4K | |||
|
|||||||
IGS | Ann: Appendix 3B | 20/09/18 | 0 | 1.1K | |||
|
|||||||
IGS | Ann: Results of Annual General Meeting | 14/09/18 | 0 | 709 | |||
|
See All Discussions